IL17A and gastric cancer: Since IL-17 is primarily associated with gastric inflammation and targets extracellular pathogens, weakened Th17 response induced by MDDC from gastric cancer patients may contribute to an impaired immunity against extracellular pathogens, thereby favoring bacterial persistence in cancer patients.